# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0000950170-25-004563
Filing Date
2025-01-13
Accepted
2025-01-13 07:15:14
Documents
46
Period of Report
2025-01-13
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | olma-20250113.htm iXBRL | 8-K | 40900
2 | EX-99.1 INVESTOR PRESENTATION, DATED JANUARY 13, 2025, OF OLEMA PHARMACEUTICALS, | olma-ex99_1.htm | EX-99.1 | 49720
3 | GRAPHIC | olma-ex99_1s1.jpg | GRAPHIC | 237794
4 | GRAPHIC | olma-ex99_1s2.jpg | GRAPHIC | 984920
5 | GRAPHIC | olma-ex99_1s3.jpg | GRAPHIC | 451748
6 | GRAPHIC | olma-ex99_1s4.jpg | GRAPHIC | 388809
7 | GRAPHIC | olma-ex99_1s5.jpg | GRAPHIC | 345368
8 | GRAPHIC | olma-ex99_1s6.jpg | GRAPHIC | 357803
9 | GRAPHIC | olma-ex99_1s7.jpg | GRAPHIC | 360243
10 | GRAPHIC | olma-ex99_1s8.jpg | GRAPHIC | 319380
11 | GRAPHIC | olma-ex99_1s9.jpg | GRAPHIC | 406639
12 | GRAPHIC | olma-ex99_1s10.jpg | GRAPHIC | 439299
13 | GRAPHIC | olma-ex99_1s11.jpg | GRAPHIC | 292934
14 | GRAPHIC | olma-ex99_1s12.jpg | GRAPHIC | 363737
15 | GRAPHIC | olma-ex99_1s13.jpg | GRAPHIC | 355287
16 | GRAPHIC | olma-ex99_1s14.jpg | GRAPHIC | 387307
17 | GRAPHIC | olma-ex99_1s15.jpg | GRAPHIC | 434474
18 | GRAPHIC | olma-ex99_1s16.jpg | GRAPHIC | 411294
19 | GRAPHIC | olma-ex99_1s17.jpg | GRAPHIC | 398310
20 | GRAPHIC | olma-ex99_1s18.jpg | GRAPHIC | 413331
21 | GRAPHIC | olma-ex99_1s19.jpg | GRAPHIC | 575264
22 | GRAPHIC | olma-ex99_1s20.jpg | GRAPHIC | 311826
23 | GRAPHIC | olma-ex99_1s21.jpg | GRAPHIC | 302631
24 | GRAPHIC | olma-ex99_1s22.jpg | GRAPHIC | 416499
25 | GRAPHIC | olma-ex99_1s23.jpg | GRAPHIC | 358473
26 | GRAPHIC | olma-ex99_1s24.jpg | GRAPHIC | 300901
27 | GRAPHIC | olma-ex99_1s25.jpg | GRAPHIC | 277709
28 | GRAPHIC | olma-ex99_1s26.jpg | GRAPHIC | 401830
29 | GRAPHIC | olma-ex99_1s27.jpg | GRAPHIC | 316698
30 | GRAPHIC | olma-ex99_1s28.jpg | GRAPHIC | 446415
31 | GRAPHIC | olma-ex99_1s29.jpg | GRAPHIC | 458940
32 | GRAPHIC | olma-ex99_1s30.jpg | GRAPHIC | 477617
33 | GRAPHIC | olma-ex99_1s31.jpg | GRAPHIC | 344477
34 | GRAPHIC | olma-ex99_1s32.jpg | GRAPHIC | 330300
35 | GRAPHIC | olma-ex99_1s33.jpg | GRAPHIC | 409444
36 | GRAPHIC | olma-ex99_1s34.jpg | GRAPHIC | 158733
| Complete submission text file | 0000950170-25-004563.txt |  | 18449940

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
37 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | olma-20250113.xsd | EX-101.SCH | 24998
48 | EXTRACTED XBRL INSTANCE DOCUMENT | olma-20250113_htm.xml | XML | 4749

Mailing Address 780 BRANNAN STREET SAN FRANCISCO CA 94103
Business Address 780 BRANNAN STREET SAN FRANCISCO CA 94103 (415) 651-3316
Olema Pharmaceuticals, Inc. (Filer) CIK: 0001750284 (see all company filings)

EIN.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39712 | Film No.: 25524791
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)